Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline [View article]
You might want to read this blog article from The Street. SPPI is the 4th company to try and make money on Zevalin so make sure you're comfortable with the risk if you invest.
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline [View article]
www.thestreet.com/stor...